NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 47 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -63.2% | 82,199 | -0.4% | 0.00% | – |
| Q2 2022 | $87,000 | -43.9% | 82,499 | +0.4% | 0.00% | – |
| Q1 2022 | $155,000 | -33.2% | 82,199 | -0.2% | 0.00% | – |
| Q4 2021 | $232,000 | -38.6% | 82,391 | -21.4% | 0.00% | – |
| Q3 2021 | $378,000 | -28.0% | 104,796 | -4.5% | 0.00% | – |
| Q2 2021 | $525,000 | -31.8% | 109,685 | +5.2% | 0.00% | – |
| Q1 2021 | $770,000 | +23.2% | 104,235 | +16.6% | 0.00% | – |
| Q4 2020 | $625,000 | -5.0% | 89,371 | +3.1% | 0.00% | – |
| Q3 2020 | $658,000 | +439.3% | 86,724 | +523.9% | 0.00% | – |
| Q2 2020 | $122,000 | – | 13,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 868,699 | $4,161,000 | 1.03% |
| Greenlight Capital | 2,727,027 | $13,062,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 345,500 | $1,655,000 | 0.55% |
| GSA CAPITAL PARTNERS LLP | 346,151 | $1,658,000 | 0.19% |
| Tibra Equities Europe Ltd | 66,400 | $318,000 | 0.10% |
| Opal Wealth Advisors, LLC | 20,000 | $96,000 | 0.09% |
| Stonepine Capital Management, LLC | 31,070 | $149,000 | 0.08% |
| Frontier Wealth Management LLC | 145,000 | $695,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,490,000 | 0.04% |
| PERKINS CAPITAL MANAGEMENT INC | 14,800 | $71,000 | 0.04% |